A Swiss startup develops a device to concentrate protein fraction from human milk onsite in hospitals for premature infants with <1.5kg birth weight. They search for hospitals or milk donor bank for a Eurostars research cooperation for the study of the detailed composition of the fractions, demonstration of biosafety, hygiene and food safety of the ones for the preterm nutrition and to run a first trial to study the effect of novel protein fortifier for clinical outcomes of preterm neonates.
Plazo para presentar expresiones de interés finaliza el 31 de julio de 2021
La fecha límite de la convocatoria es 4 de septiembre de 2021
Solicite mayor información mencionando el código de referencia desde aquí
